Headline News about Sarepta Therapeutics
![](https://g.foolcdn.com/editorial/images/781823/doctor-and-businessman-working-on-digital-tablet-in-the-office.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/782122/a-doctor-looking-at-a-tablet-with-another-person.jpg)
![](https://g.foolcdn.com/editorial/images/781683/physician-giving-a-high-five-to-a-young-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_4.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/781349/business-people-and-doctors-talking-on-a-meeting-in-hospital.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU6.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/23/draftkings-shutter3.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2018/03/ibdstocksupdate5.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/21/chart-ai3.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/06/21/Wall-Street-trader.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/21/movers-image_12.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/06/21/pharma-lab-worker-ai.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/21/Wall-Street.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/21/Genetic-Research-And-Biotech-Science-Con.jpeg?width=1200&height=800&fit=crop)
Sarepta's Expanded FDA Approval For Elevidys Potentially Shaping Future FDA Reviews, Analyst Says
June 21, 2024
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2024/06/21/Gold-goldbar-goldnugget-shutterstock.jpeg?width=1200&height=800&fit=crop)
Gold Down 1%; CarMax Shares Gain After Q1 Earnings
June 21, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2020/12/solar-stocks-1600-1024x576.jpg)
![](https://investorplace.com/wp-content/uploads/2024/04/ai-stocks1600-7.png)
![](https://cdn.benzinga.com/files/images/story/2024/06/21/movers-image_11.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2019/04/stock-NYSE-exterior-03-adobe.jpg)
![](https://image.thefly.com/catalog/202112/img_1285.jpg)
![](https://investorplace.com/wp-content/uploads/2024/06/srpt1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/06/21/Movers.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.